Nanobiotix (NBTX) Retained Earnings (2019 - 2025)
Nanobiotix (NBTX) recorded quarterly Retained Earnings of -$438.7 million in Q4 2025, down 2.46% quarter-over-quarter from -$428.1 million in Q2 2025, and down 31.48% on a YoY basis from -$640.2 million in Q4 2024.
Nanobiotix (NBTX) Retained Earnings (2019 - 2025) Analysis & Trends
Nanobiotix's Retained Earnings history runs 7 years deep, the most recent figure standing at -$438.7 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 31.48% year-over-year to -$438.7 million; the TTM figure through Dec 2025 stood at -$438.7 million (down 31.48% YoY), while the FY2025 annual figure was -$425.8 million, down 27.61% from the prior year.
- Retained Earnings was -$438.7 million for Q4 2025 at Nanobiotix, down from -$428.1 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $792589.3 in Q2 2024 to a low of -$438.7 million in Q4 2025.
- Historically, Retained Earnings has averaged -$173.2 million across 5 years, with a median of -$134.0 million in 2021.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings surged 100.32% in 2022, then slumped 54116.17% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$209.9 million in 2021, then surged by 72.27% to -$58.2 million in 2022, then climbed by 26.6% to -$42.7 million in 2023, then sank by 681.08% to -$333.6 million in 2024, then plunged by 31.48% to -$438.7 million in 2025.
- The last three Retained Earnings figures came in at -$438.7 million (Q4 2025), -$428.1 million (Q2 2025), and -$333.6 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -838.07 Mn |
| 10 | Nanobiotix | 57.94 Mn | -3.46 Mn | - | -438.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -438.66 Mn |
| Jun 30, 2025 | -428.13 Mn |
| Dec 31, 2024 | -333.64 Mn |
| Jun 30, 2024 | 792,589.26 |
| Dec 31, 2023 | -42.71 Mn |
| Jun 30, 2023 | 773,136.32 |
| Dec 31, 2022 | -58.20 Mn |
| Jun 30, 2022 | 723,464.43 |
| Dec 31, 2021 | -209.87 Mn |
| Jun 30, 2021 | -223.12 Mn |
| Dec 31, 2020 | 661,720.87 |
| Dec 31, 2019 | 479,282.36 |